checkAd

     386  0 Kommentare Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury - Seite 3

    Source:

    1. https://www.cdc.gov/traumaticbraininjury/pdf/moderate_to_severe_tbi_li ...

     

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury - Seite 3 TORONTO, April 27, 2021 (GLOBE NEWSWIRE) - Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, …